{"entity":{"type":"insider","cik":"0001636642","url":"/insider/0001636642","json_url":"/insider/0001636642.json","name":"Donley Matthew Maxwell","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2021-05-12","last":"2025-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Donley Matthew Maxwell","source":"filing","n_filings":5,"first_seen":"2021-05-12","last_seen":"2025-03-04"}],"transactions":[{"id":4600358,"accession":"0001600620-25-000018","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001600620-25-000018","line_url":"/filing/0001600620-25-000018#line-4","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001636642","owner_name":"Donley Matthew Maxwell","owner_display_name":"Donley Matthew Maxwell","owner_url":"/insider/0001636642","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58991.0,"shares_display":"58,991","price_per_share":7.92,"price_display":"7.92","price_state":"stated","total_value":467208.72,"total_display":"467,208.72","total_whole":"467,209","shares_owned_after":680465.0,"shares_owned_after_display":"680,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-04","scope":"insider"},{"id":4600348,"accession":"0001600620-25-000018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001600620-25-000018","line_url":"/filing/0001600620-25-000018#line-3","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001636642","owner_name":"Donley Matthew Maxwell","owner_display_name":"Donley Matthew Maxwell","owner_url":"/insider/0001636642","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65902.0,"shares_display":"65,902","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":527216.0,"total_display":"527,216.00","total_whole":"527,216","shares_owned_after":739456.0,"shares_owned_after_display":"739,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":2429117,"accession":"0001600620-24-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600620-24-000036","line_url":"/filing/0001600620-24-000036#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001636642","owner_name":"Donley Matthew Maxwell","owner_display_name":"Donley Matthew Maxwell","owner_url":"/insider/0001636642","role":"Officer (EVP, Ops & Strategy)","role_mark":"O","role_mark_label":"Officer (EVP, Ops & Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Ops & Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40665.0,"shares_display":"40,665","price_per_share":5.51,"price_display":"5.51","price_state":"stated","total_value":224064.15,"total_display":"224,064.15","total_whole":"224,064","shares_owned_after":584072.0,"shares_owned_after_display":"584,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-07","scope":"insider"},{"id":6461266,"accession":"0001628280-22-030745","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-030745","line_url":"/filing/0001628280-22-030745#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001636642","owner_name":"Donley Matthew Maxwell","owner_display_name":"Donley Matthew Maxwell","owner_url":"/insider/0001636642","role":"Officer (Ex VP, Internal Operations)","role_mark":"O","role_mark_label":"Officer (Ex VP, Internal Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Ex VP, Internal Operations","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.66,"price_display":"4.66","price_state":"stated","total_value":46600.0,"total_display":"46,600.00","total_whole":"46,600","shares_owned_after":27927.0,"shares_owned_after_display":"27,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-23","scope":"insider"},{"id":6499291,"accession":"0001628280-22-005129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-22-005129","line_url":"/filing/0001628280-22-005129#line-2","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001636642","owner_name":"Donley Matthew Maxwell","owner_display_name":"Donley Matthew Maxwell","owner_url":"/insider/0001636642","role":"Officer (Ex VP, Intern'l Operations)","role_mark":"O","role_mark_label":"Officer (Ex VP, Intern'l Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Ex VP, Intern'l Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3052.0,"shares_display":"3,052","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":36654.52,"total_display":"36,654.52","total_whole":"36,655","shares_owned_after":16224.0,"shares_owned_after_display":"16,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-04","scope":"insider"},{"id":4110335,"accession":"0001628280-21-010023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-010023","line_url":"/filing/0001628280-21-010023#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001636642","owner_name":"Donley Matthew Maxwell","owner_display_name":"Donley Matthew Maxwell","owner_url":"/insider/0001636642","role":"Officer (Ex VP, Intern'l Operations)","role_mark":"O","role_mark_label":"Officer (Ex VP, Intern'l Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Ex VP, Intern'l Operations","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9900.0,"shares_display":"9,900","price_per_share":10.0746,"price_display":"10.07","price_state":"stated","total_value":99738.54,"total_display":"99,738.54","total_whole":"99,739","shares_owned_after":9900.0,"shares_owned_after_display":"9,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600620","name":"Aurinia Pharmaceuticals Inc.","url":"/issuer/0001600620","role":"Officer (Chief Operating Officer)","n_filings":5,"first_seen":"2021-05-12","last_seen":"2025-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001636642","retrieved_at":"2026-08-24T13:11:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}